91 related articles for article (PubMed ID: 1535073)
1. Novel selective serotonin reuptake inhibitors, Part II.
J Clin Psychiatry; 1992 Jun; 53(6):216-21. PubMed ID: 1535073
[No Abstract] [Full Text] [Related]
2. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
J Clin Psychiatry; 1992 Feb; 53 Suppl():44-7. PubMed ID: 1531824
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
Cohn JB; Wilcox CS
J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled study of paroxetine in depressed outpatients.
Kiev A
J Clin Psychiatry; 1992 Feb; 53 Suppl():27-9. PubMed ID: 1531818
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of paroxetine compared with placebo in outpatients with major depression.
Rickels K; Amsterdam J; Clary C; Fox I; Schweizer E; Weise C
J Clin Psychiatry; 1992 Feb; 53 Suppl():30-2. PubMed ID: 1531820
[TBL] [Abstract][Full Text] [Related]
6. The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Tulloch IF; Johnson AM
J Clin Psychiatry; 1992 Feb; 53 Suppl():7-12. PubMed ID: 1531829
[TBL] [Abstract][Full Text] [Related]
7. Novel selective serotonin reuptake inhibitors, Part I.
J Clin Psychiatry; 1992 Mar; 53(3):107-12. PubMed ID: 1532176
[No Abstract] [Full Text] [Related]
8. Therapeutic effects of serotonin uptake inhibitors in depression.
Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
[TBL] [Abstract][Full Text] [Related]
9. The safety profile of paroxetine.
Boyer WF; Blumhardt CL
J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
[TBL] [Abstract][Full Text] [Related]
10. Depression and selective serotonin reuptake inhibitors.
Westwick F
Br J Hosp Med; 1990 Nov; 44(5):367. PubMed ID: 2148896
[No Abstract] [Full Text] [Related]
11. Clinical overview of serotonin reuptake inhibitors.
Rickels K; Schweizer E
J Clin Psychiatry; 1990 Dec; 51 Suppl B():9-12. PubMed ID: 2147922
[TBL] [Abstract][Full Text] [Related]
12. Paroxetine in the treatment of depression: a comparison with imipramine and placebo.
Feighner JP; Boyer WF
Acta Psychiatr Scand Suppl; 1989; 350():125-9. PubMed ID: 2530763
[TBL] [Abstract][Full Text] [Related]
13. Serotonin-specific drugs for anxiety and depressive disorders.
Charney DS; Krystal JH; Delgado PL; Heninger GR
Annu Rev Med; 1990; 41():437-46. PubMed ID: 2139556
[TBL] [Abstract][Full Text] [Related]
14. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant effects of 5-HT uptake inhibitors.
Aberg-Wistedt A
Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
[TBL] [Abstract][Full Text] [Related]
16. A clinical profile of paroxetine: a novel selective serotonin reuptake inhibitor (SSRI).
J Clin Psychiatry; 1992 Feb; 53 Suppl():1-68. PubMed ID: 1531815
[No Abstract] [Full Text] [Related]
17. The predictive value of the dexamethasone suppression test. A placebo-controlled study.
Peselow ED; Stanley M; Filippi AM; Barouche F; Goodnick P; Fieve RR
Br J Psychiatry; 1989 Nov; 155():667-72. PubMed ID: 2532946
[TBL] [Abstract][Full Text] [Related]
18. [Adverse effects: priapism caused by paroxetine].
Bertholon F; Krajewski Y; el Allali A
Ann Med Psychol (Paris); 1996 May; 154(2):145-6; discussion 146-7. PubMed ID: 8694403
[TBL] [Abstract][Full Text] [Related]
19. The short- and long-term efficacy of paroxetine HCl: A. Data from a 6-week double-blind parallel design trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):267-71. PubMed ID: 2532373
[No Abstract] [Full Text] [Related]
20. The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo.
Peselow ED; Filippi AM; Goodnick P; Barouche F; Fieve RR
Psychopharmacol Bull; 1989; 25(2):272-6. PubMed ID: 2532374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
